Author:
Macheras Panos,Tsekouras Athanasios A.
Publisher
Springer International Publishing
Reference21 articles.
1. Macheras P (2019) On an unphysical hypothesis of Bateman equation and its implications for pharmacokinetics. Pharm Res 36:94. https://doi.org/10.1007/s11095-019-2633-4
2. Macheras P, Chryssafidis P (2020) Revising pharmacokinetics of oral drug absorption: I Models based on biopharmaceutical/physiological and finite absorption time concepts. Pharm Res 37:187. https://doi.org/10.1007/s11095-020-02894-w. (Erratum, Pharm. Res. 37, 206 (2020) https://doi.org/10.1007/s11095-020-02935-4)
3. Abuhelwa A, Foster D, Upton R (2016) A quantitative review and meta-models of the variability and factors affecting Oral drug absorption-part II: gastrointestinal transit time. AAPS J 18:1322–1333. https://doi.org/10.1208/s12248-20016-209953-207
4. Iranpour P, Lall C, Houshyar R, Helmy M, Yang A, Choi JI, Ward G, Goodwin SC (2016) Altered Doppler flow patterns in cirrhosis patients: an overview. Ultrasonography 35:3–12. https://doi.org/10.14366/usg.15020
5. Food and Drug Administration (2017) Center for Drug Evaluation and Research (CDER). Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. Guidance for Industry U.S. Department of Health and Human Services